What Happened The Announcement Explained How We Got Here The FDA Category System and the 2023 Restriction Which Peptides Are Expected to Return and What the Science Says Why Physician Oversight Matters More After This Announcement, Not Less What Patients Should Do Now The Practical Roadmap What This Means for the Future of Longevity Medicine FAQ: About BPC-157 Peptide BPC-157 FDA Status 2026: What the RFK Reclassification Means for Patients | AgeMD BPC-157 FDA Status 2026: What the RFK Reclassification Means for Patients | AgeMD A guide to the 2026 FDA peptide reclassification what changed, which compounds are returning, and what patients should do next
Animal research has examined its potential to accelerate tissue repair, promote angiogenesis (new blood vessel formation), reduce localized inflammation, support gut and ulcer healing, and enhance tendon and ligament recovery
Peptide Quality and Purity Verification The unregulated nature of the research peptide market introduces risks entirely separate from BPC-157s inherent properties
Most side effects are dose-dependent, meaning lower doses produce fewer issues
Immunobiology 216, 322333
